122 related articles for article (PubMed ID: 38232664)
1. Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase attenuate RANKL-induced osteoclast differentiation and rheumatoid arthritis.
Su Y; Han Y; Choi HS; Lee GY; Cho HW; Choi H; Choi JH; Jang YS; Seo JW
Biomed Pharmacother; 2024 Feb; 171():116153. PubMed ID: 38232664
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Wang-Bi tablet on bone destruction in collagen-induced arthritis by regulating osteoclast-osteoblast functions.
Shen W; Guan YY; Wu RM; Liu LX; Li HD; Bao WL; Zhang Y; Nandakumar KS; Ye G; Shen X
J Ethnopharmacol; 2019 Jun; 238():111861. PubMed ID: 30954617
[TBL] [Abstract][Full Text] [Related]
3. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
Konda VR; Desai A; Darland G; Bland JS; Tripp ML
Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
[TBL] [Abstract][Full Text] [Related]
4. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
5. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model.
Zhao R; Chen NN; Zhou XW; Miao P; Hu CY; Qian L; Yu QW; Zhang JY; Nie H; Chen XH; Li P; Xu R; Xiao LB; Zhang X; Liu JR; Zhang DQ
J Transl Med; 2014 Dec; 12():330. PubMed ID: 25491303
[TBL] [Abstract][Full Text] [Related]
6. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
Doss HM; Samarpita S; Ganesan R; Rasool M
Life Sci; 2018 Aug; 207():284-295. PubMed ID: 29908722
[TBL] [Abstract][Full Text] [Related]
7. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors.
Hu L; Liu R; Zhang L
Int Immunopharmacol; 2022 Oct; 111():109095. PubMed ID: 35926270
[TBL] [Abstract][Full Text] [Related]
8. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
[TBL] [Abstract][Full Text] [Related]
9. Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7.
Gan K; Xu L; Feng X; Zhang Q; Wang F; Zhang M; Tan W
Int Immunopharmacol; 2015 Feb; 24(2):239-246. PubMed ID: 25529994
[TBL] [Abstract][Full Text] [Related]
10. A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.
Cheng CP; Huang HS; Hsu YC; Sheu MJ; Chang DM
J Clin Immunol; 2012 Aug; 32(4):762-77. PubMed ID: 22396044
[TBL] [Abstract][Full Text] [Related]
11. Guizhi Shaoyao Zhimu granules attenuate bone destruction in mice with collagen-induced arthritis by promoting mitophagy of osteoclast precursors to inhibit osteoclastogenesis.
Yao H; Xiang L; Huang Y; Tan J; Shen Y; Li F; Geng F; Liu W; Li X; Gao Y
Phytomedicine; 2023 Sep; 118():154967. PubMed ID: 37490802
[TBL] [Abstract][Full Text] [Related]
12. Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model.
Atkinson SM; Bleil J; Maier R; Kühl AA; Thorn M; Serikawa K; Fox B; Kruse K; Haase C; Skov S; Nansen A; Syrbe U
Arthritis Res Ther; 2016 Jan; 18():28. PubMed ID: 26801240
[TBL] [Abstract][Full Text] [Related]
13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
Rahman MM; Bhattacharya A; Fernandes G
J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
[TBL] [Abstract][Full Text] [Related]
15. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
Weiss RJ; Erlandsson Harris H; Wick MC; Wretenberg P; Stark A; Palmblad K
Scand J Immunol; 2005 Jul; 62(1):55-62. PubMed ID: 16092922
[TBL] [Abstract][Full Text] [Related]
16. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
17. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis.
Zhu M; Yu B; Bai J; Wang X; Guo X; Liu Y; Lin J; Hu S; Zhang W; Tao Y; Hu C; Yang H; Xu Y; Geng D
J Bone Miner Res; 2019 Apr; 34(4):739-751. PubMed ID: 30508319
[TBL] [Abstract][Full Text] [Related]
19. Melittin acupoint injection in attenuating bone erosion in collagen-induced arthritis mice via inhibition of the RANKL/NF-κB signaling pathway.
Liu F; Chen F; Yang L; Qiu F; Zhong G; Gao S; Xi W; Lai M; He Q; Chen Y; Chen W; Zhang J; Yang L
Quant Imaging Med Surg; 2023 Sep; 13(9):5996-6013. PubMed ID: 37711782
[TBL] [Abstract][Full Text] [Related]
20. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
